Completed OBSERVATIONAL NCT01001559

Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

Combination Deplin® and Antidepressant Therapy Compared to Antidepressant Therapy Alone for an Episode of Major Depression- a Retrospective Analysis

Sponsor: Baylor Health Care System

Conditions Major Depressive Disorder

Interventions L-methylfolate Selective serotonin reuptake inhibitor (SSRI) Serotonin and norepinephrine reuptake inhibitor (SNRI)

Updated 9 times since 2017 Last updated: Nov 25, 2013 Started: Aug 31, 2009 Primary completion: Dec 31, 2010 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Major Depressive Disorder and is currently completed. Baylor Health Care System leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baylor Health Care System
Pamlab, Inc.
Red Oak Psychiatry Associates, PA

Data source: Pamlab, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States